Exploring the ATR-CHK1 pathway in the response of doxorubicin-induced DNA damages in acute lymphoblastic leukemia cells
Andrea Ghelli Luserna di Rorà(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Giorgia Simonetti(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori)
Cited by 26
Related Papers
Kevetrin induces apoptosis in TP53 wild‑type and mutant acute myeloid leukemia cells
|Oncology Reports|2020|16